Lamivudine

MOQ100 Pack/Packs

Storagekeep at cool and dry place

UsageClinical, Hospital

DosageAs per prescription

Medicine TypeAnti HIV Tablets

Drug TypeGeneral Medicines

IngredientsLamivudine Zidovudine Tablet

MOQ1000 Box/Boxes

DosageAs directed by physician.

GradePharma

StorageStore in a cool and dark place.

AppearanceTablet

Origin of MedicineIndia

MOQ100 Kilograms/Kilograms

ColorWhite

Shelf Life5 years if properly stored

HS Code29335990

Heavy Metal (%)0.001%

StorageOther, Store in a cool, dry place, away from light

TasteBitter

MOQ350 Bottle/Bottles, Bottle/Bottles, Bottle/Bottles

Physical FormLiquid

FunctionAnti-Bacterial

Recommended ForDoctor

Dosage GuidelinesAs Suggested

Storage InstructionsCool And Dry Place

MOQ1 Kilograms/Kilograms

Loss on DryingNot more than 0.5%

StorageOther, Store in a tightly closed container, in a cool, dry place, away from light.

Molecular Weight229.26 g/mol

EINECS No620-054-5

Heavy Metal (%)Not more than 20 ppm

Molecular FormulaC8H11N3O3S

MOQ100 Box/Boxes

Drug TypeOther Types

IngredientsLamivudine + Zidovudine + Efavirenz Tablets

Physical FormTablets

FunctionOther

DosageAs directed by doctor.

Dosage GuidelinesAs directed by physician.

MOQ1 Box/Boxes

Drug TypeGeneral Medicines

IngredientsLamivudine

Physical FormTablets

FunctionAnti-Malaria

Dosage300 mg

Dosage GuidelinesAs per prescription

Molecular formulaC8H11N3O3S

Molar mass229.25 g/mol

AppearanceWhite powder

SolubilityWater soluble

Melting point196-200 °C

StorageControlled room temperature

MOQ1 Kilograms/Kilograms

Structural FormulaC8H11N3O3S

TasteOther

Heavy Metal (%)Not more than 0.002%

Molecular FormulaC8H11N3O3S

HS Code2938901000

Melting Point174a,,f ~ 179a,,f

MOQ500 Bottle/Bottles

Pacakaging (Quantity Per Box)30 tablets

IndicationUsed to treat human immunodeficiency virus (HIV-1) infection in adults and children weighing at least 25 kg.

Packaging TypeBottle

Salt CompositionAbacavir Lamivudine

Life Span24 Months

Dosage FormTablet

MOQ25 Kilograms/Kilograms

ApplicationPharmaceutical Industry, Other, Cosmetic Industry, Animal Pharmaceutical, Biomedical Fields

FormPowder, Gas, Liquid, Solid, Other

MOQ1 Tablet

DosagePRESCRIBED BY DOCTOR

UsagePRESCRIBED BY DOCTOR

Drug TypeOther Types

IngredientsLamivudine (300mg) + Tenofovir disoproxil fumarate (300mg)

Physical FormTablets

FunctionOther

MOQ1 Bottle/Bottles

Pacakaging (Quantity Per Box)10 strips per box

Salt CompositionLamivudine 150 mg

Origin of MedicineAllopathic

IndicationHIV-1 infection, chronic hepatitis B

Dosage FormTablet

Drug TypeOther, Antiretroviral agent

MOQ500 Box/Boxes

Salt CompositionEfavirenz/Lamivudine/Tenofovir Disoproxil Fumarate 600 mg/300 mg/300 mg Tablets is a combination of three antiviral medicines used to treat Human Immunodeficiency Virus (HIV) infection in adults and adolescents. Antiviral medicines used for HIV infection are known as antiretrovirals.

IndicationEfavirenz/Lamivudine/Tenofovir Disoproxil Fumarate 600 mg/300 mg/300 mg Tablets is a combination of three antiviral medicines used to treat Human Immunodeficiency Virus (HIV) infection in adults and adolescents. Antiviral medicines used for HIV infection are known as antiretrovirals.

Dosage FormTablets

Origin of MedicineIndia

Pacakaging (Quantity Per Box)30 tablets per box

Drug TypeSpecific Drug

MOQ25 Kilograms/Kilograms

StorageRoom Temperature

TypeOther, Lamotrizine usp

GradeMedicine Grade

Purity(%)High

Physical FormPowder

MOQ100 Piece/Pieces

StorageStore below 30AdegC in a dry place protect from light

IndicationTreatment of HIV-1 infection

Expiration Date2 years from the date of manufacturing

CAS No134678-17-4 (Lamivudine) 147127-20-6 (Tenofovir disoproxil fumarate) 154598-52-4 (Efavirenz)

Molecular FormulaC8H11N3O3S (Lamivudine) C19H30N5O10P (Tenofovir disoproxil fumarate) C14H9ClF3NO2 (Efavirenz)

Salt CompositionLamivudine + Tenofovir disoproxil fumarate + Efavirenz